LO Funds- Swiss Equity, Syst. NAV Hdg, (EUR) MARegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | 16.7 | -16.7 | 2.7 | 5.8 | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 26/04/2024 | EUR 12.83 | |
Day Change | 0.66% | |
Morningstar Category™ | Other Equity | |
ISIN | LU1093750633 | |
Fund Size (Mil) 26/04/2024 | CHF 188.03 | |
Share Class Size (Mil) 19/01/2024 | EUR 0.13 | |
Max Initial Charge | - | |
Ongoing Charge 06/02/2024 | 1.18% |
Investment Objective: LO Funds- Swiss Equity, Syst. NAV Hdg, (EUR) MA |
The Sub-Fund is actively managed. The SPI TR index is used to define the initial investment universe for individual security selection, for performance comparison as well as for internal risk monitoring purposes, without implying any particular constraints to the Sub-Fund's investments. The Sub-Fund’s securities will generally be similar to those of the above-mentioned index but the security weightings are expected to differ materially. The Investment Manager may also select securities not included in the above-mentioned index in order to take advantage of investment opportunities. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Johan Utterman 18/11/2015 | ||
Fabian Weiderin 27/02/2020 | ||
Inception Date 14/05/2020 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
SIX SPI TR CHF | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for LO Funds- Swiss Equity, Syst. NAV Hdg, (EUR) MA | 29/02/2024 |
|
|
Top 5 Holdings | Sector | % |
Roche Holding AG | Healthcare | 9.58 |
Novartis AG Registered Shares | Healthcare | 9.55 |
Nestle SA | Consumer Defensive | 8.95 |
UBS Group AG | Financial Services | 5.01 |
Compagnie Financiere Richemont S... | Consumer Cyclical | 4.91 |
Increase Decrease New since last portfolio | ||
LO Funds- Swiss Equity, Syst. NAV Hdg, (EUR) MA |